40results about How to "Reduce skin inflammation" patented technology

Disclosed is a topical skin care composition that includes water, silymarin, hydrolyzed algin, palmitoyl tripeptide 8, ceramide 2, pomegranate extract comprising pomegranate sterols, glycerin, disodium EDTA, caprylic / capric triglyceride, shea butter, C12-15 alcohols benzoate, dimethicone, glyceryl stearate and PEG 100 stearate, cetyl alcohol, stearyl alcohol, stearic acid, butylene glycol, caprylyl glycol, and (s) a mixture of acrylamide / sodium acryloyldimethyl taurate copolymer, isohexadecane, and polysorbate 80.

Disclosed are compositions and corresponding methods of their use that include Nymphaea gigantea, Syzygium moorei, Cupaniopsis anacardioides, Archidendron hendersonii, Tristaniopsis laurina, Brachychiton acerifolius, Stenocarpus sinuatus, Alphitonia excelsa, Eucalyptus coolabah, Plumeria alba, Cocos nucifera, or Tamarindus indica extract.

A method for treating skin, reducing oxidative damage to a skin cell, reducing lipoxygenase (LO) activity in a skin cell, reducing cyclooxygenase (COX) activity in a skin cell, reducing tumor necrosis factor alpha (TNF-α) in a skin cell, or reduction matrix metalloproteinase enzyme activity in a skin cell comprising contacting skin or a skin cell with an aromatic skin-active ingredient.

The present invention relates to skin care compositions, including cosmeceuticals, for topical application, and more particularly, a skin cream, comprising exosomes and cell culture medium conditioned by cells grown in two-dimensional culture. Also included are methods of making and using such compositions and kits comprising the skin cream therein.

A cosmeceutically acceptable formulation as a wound dressing including red palm oil and a triglyceride, preferably fish oil, preferably derived from salmon. Another aspect of this disclosure is providing a mixture of red palm oil and very long chain (>C>18) omega 3 and 6 fatty acids. The formulation may also include one or more of the following: coconut oil and shea butter for anti-inflammatory activity and antimicrobial efficacy, fish collagen, an acidic preservative, a cationic surfactant, and various vitamins.

A mixture of an aqueous solution, essential oils and mechanically extracted Phaeophyte kelp cytoplasm results in an emulsion with cosmetic and therapeutic properties. The preparation may be used on human and animal hair or skin. The moisturizing properties of the kelp cytoplasm provide the aqueous solution to the hair (keratin) which is absorbed, causing the hair to swell, and become heavier and more pliable. The natural oxidation agent preserves the mixture as well as providing a fresh oxygen in a spray when used. The alginate gels and oils in the emulsion coat the hair strands to reduce breakage and splitting and add weight to the strand. The preparation dries with gel capsules, which release moisture over time for a long-lasting effect. The preparation also contains, and may be supplemented with fuciodans, iodine, phlorotannins which reduce inflammation, prevent scaly skin, and act as an antibiotic, respectively, on dry chapped skin. The preparation seals off the cracks from the environment while trapping moisture pockets. This provides an environment conducive for healing.

Disclosed is a non-ionic oil-in water emulsion comprising less than 50% by weight of water, a combination of non-ionic emulsifiers and non-ionic emulsion stabilizers, a combination of humectant skin conditioning agents, and a combination of UV absorbing agents. The emulsion can be stable and have an SPF of at least 30.

A method of making a low molecular weight fraction of Phyllanthus niruri is provided. Such low molecular weight fraction is particularly useful for treating the skin, for example skin in need of treatment for signs of aging, for reducing inflammation, or for skin lightening.

Disclosed is a topical skin composition and corresponding methods for its use that includes a first MMP-1 inhibitor, wherein said first inhibitor is an extract from Burretiodendron hsienmu, a second MMP-1 inhibitor, wherein said second inhibitor is an extract from Bauhinia brachycarpa var. cavaleriei, and a third MMP-1 inhibitor, wherein said third inhibitor is an extract from Tetracentron sinense.

The present invention relates generally to methods of use and compositions useful for treating skin. The composition includes a combination of saccharide isomerate extract, Myrothamnus flabellifolia extract, algae extract, mugwort (Artemisia vulgaris) extract, and [6]-paradol. This combination can be used to create topical skin compositions that reduces erythema, cools the skin, inhibits nitric oxide synthase, decreases TNF-α production, and increases the production of occludin-1.

A reduced water mist generating device (1) is provided with a water acquiring section (3) that acquires water for generating reduced water, a reduced water generating unit (U) that generates the reduced water from the acquired water, a reduced water atomizing section (6) that atomizes the generated reduced water, and a spraying section (7) that sprays the atomized water. With such a configuration, the reduced water can be generated from water, drifted in the form of a mist in a space, and caused to arrive at an object.

The present invention provides an external preparation for skin which contains, as a major ingredient, oleaginous substances extracted from sporoderm-broken spores from Ganoderma lucidum. The spores are preferably being treated with germination activation. The oleaginous substances are preferred to be extracted by a supercritical fluid-carbon dioxide (SCF-CO2) method. The oleaginous substances prepared by SCF-CO2 is transparent and odorless. They also demonstrates effects on skin smoothening, wrinkles reduction, aging defiance, inflammation lessening, pigmentation lightening, and irritation alleviation. The external preparation can be a cosmetic or a therapeutic composition.

Disclosed are topical skin compositions and corresponding methods for their use that include plant extracts. One such composition can include a TNF-α inhibitor, wherein said inhibitor is an aqueous extract from the whole plant of Polygonum multiflorum, an antioxidant and a tyrosinase inhibitor, wherein said antioxidant and tyrosinase inhibitior is an aqueous extract from the whole plant of Lonicera japonica, and a dermatologically acceptable carrier, wherein the composition can include at least 50% by weight of water.

Disclosed are compositions that include Docynia delavajy extract, Elaeagnus lanceolatus extract, or a combination of such extracts.

The invention relates to a traditional Chinese medicine composition, a preparation method and an application thereof. The traditional Chinese medicine composition is composed of, by weight, 20-30 parts of sunflower, 15-25 parts of chamomile, 15-25 parts of aloe, 5-15 parts of rosemary, 5-10 parts of mint, and 5-15 parts of melissa officinalis. The traditional Chinese medicine composition has reasonable formula and allows synergistic effect, not only can delay the inflammation on skin due to ultraviolet irradiation and has significant sunscreen effect, but also can remove hydroxyl free radicalsand has significant anti-aging function. By applying the composition to cosmetics, a product has stable property, has higher SPF and PFA value than conventional sunscreen products and is better in tenderness.

Disclosed is a topical skin care composition and corresponding methods for its use comprising water, a cationic surfactant, an occlusive skin conditioning agent, a humectant skin conditioning agent, and a silicone containing compound. The composition is dermatologically acceptable and is capable of moisturizing skin for at least twelve hours after topical application to skin even after multiple washings of the skin.

The disclosure relates to topical compositions and methods comprising whole, non-viable Micrococcaceae cells, wherein the cells have been processed to kill the cells while minimizing lysis. The topical compositions and methods are useful for decreasing skin inflammation and improving skin barrier function.

Disclosed is a non-ionic oil-in water emulsion comprising less than 50% by weight of water, a combination of non-ionic emulsifiers and non-ionic emulsion stabilizers, a combination of humectant skin conditioning agents, and a combination of UV absorbing agents. The emulsion can be stable and have an SPF of at least 30.

Disclosed are compositions and methods for their use for reducing tumor necrosis factor alpha (TNF-α) and / or vascular endothelial growth factor (VEGF) production in skin cells by topically applying to skin in need thereof, a composition comprising an effective amount of Opuntia ficus-indica tuna, Opuntia ficus-indica nopales, or both, or extracts thereof, to reduce TNF-α or VEGF production in skin cells.

A composition for applying to skin in need of treatment for skin barrier restoration, hydration and moisturization, the composition comprising extracts of Ampelopsis grossedentata and Albizia julibrissin. Also provided are methods for treating skin in need of skin barrier treatment, methods of treating skin to reduce the signs of aging and methods of treating skin to reduce the signs of inflammation with a composition comprising extracts of Ampelopsis grossedentata and Albizia julibrissin.

The use of a CGRP receptor antagonist compound of formula (I) for topical application is described for treating and / or preventing skin inflammatory pathologies with a neurogenic component. More specifically, use of a CGRP receptor antagonist compound of formula (I) is described for topical application for treating and / or preventing rosacea, especially type I rosacea, atopic dermatitis, psoriasis and / or acne.

A composition for applying to skin in need of treatment for skin barrier restoration, hydration and moisturization, the composition comprising extracts of Ampelopsis grossedentata and Albizia julibrissin. Also provided are methods for treating skin in need of skin barrier treatment, methods of treating skin to reduce the signs of aging and methods of treating skin to reduce the signs of inflammation with a composition comprising extracts of Ampelopsis grossedentata and Albizia julibrissin.

A method for treating skin, reducing oxidative damage to a skin cell, reducing lipoxygenase (LO) activity in a skin cell, reducing cyclooxygenase (COX) activity in a skin cell, reducing tumor necrosis factor alpha (TNF-α) in a skin cell, or reduction matrix metalloproteinase enzyme activity in a skin cell comprising contacting skin or a skin cell with an aromatic skin-active ingredient.

The invention is generally directed to compositions useful for improving the aesthetic appearance of human skin and the use of those compounds for improving the appearance of human skin, including improving skin tone, reducing the appearance of dark circles under the eyes, and reducing inflammation in the skin. The compositions typically comprise adrenergic receptor agonists.

A topical skin care composition comprising kakadu plum extract or acai berry extract, or a combination of both, is disclosed. The composition can include a high oxygen radical absorbance capacity (ORAC) value. The composition can improve the skin's visual appearance, physiological functions, clinical properties, and / or biophysical properties.

Disclosed are compositions and corresponding methods of their use that include Nymphaea gigantea, Syzygium moorei, Cupaniopsis anacardioides, Archidendron hendersonii, Tristaniopsis laurina, Brachychiton acerifolius, Stenocarpus sinuatus, Alphitonia excelsa, Eucalyptus coolabah, Plumeria alba, Cocos nucifera, or Tamarindus indica extract.

Disclosed is a topical skin care composition and corresponding methods for its use comprising water, a cationic surfactant, an occlusive skin conditioning agent, a humectant skin conditioning agent, and a silicone containing compound. The composition is dermatologically acceptable and is capable of moisturizing skin for at least twelve hours after topical application to skin even after multiple washings of the skin.

The present invention relates generally to methods of use and compositions useful for treating skin. The composition includes a combination of Phoenix dactylifera extract, tea tree oil, Myrothamnus flabellifolia extract, and saccharide isomerate. This combination can be used to create topical skin compositions that reduce rosacea, erythema, and / or inflammation, and inhibit nitric oxide synthase, increase α2A adrenergic receptor agonist activity, reduce oxidation, increase anti-oxidant capacity of a composition or of skin, inhibit cyclooxygenase-2 (COX-2) production, inhibit vascular endothelial growth factor (VEGF) production, inhibit interleukin-6 (IL-6) and interleukin-8 (IL-8) production, reduce tumor necrosis factor alpha (TNF-α) production, increase collagen stimulation, increase lysyl oxidase expression, inhibit matrix metalloproteinase 1 (MMP1) activity, increase occludin production, increase filaggrin production, and increase skin moisturization. This combination can also be used to reduce transient or persistent erythema, telangiectasia, inflammatory papules and / or pustules, transient or persistent flushing of the skin, and / or hyperplasia of a connective tissue.